OBJECTIVE—To review the effects of monotherapy with α-glucosidase inhibitors (AGIs) for
patients with type 2 diabetes, with respect to mortality, morbidity, glycemic control, insulin …

Background Alpha‐glucosidase inhibitors such as acarbose or miglitol, have the potential to
improve glycemic control in type 2 diabetes mellitus. The true value of these agents, …

Alpha-glucosidase inhibitors (AGIs) are drugs that inhibit the absorption of carbohydrates
from the gut and may be used in the treatment of patients with type 2 diabetes or impaired …

OBJECTIVE: To study the course of medically unexplained symptoms (MUS), somatisation
disorder, and hypochondriasis, and related prognostic factors. Knowledge of prognostic …

Background Acute urinary tract infections (UTI) are one of the most common bacterial
infections among women presenting to primary care. However, there is a lack of consensus …

Objective Neuralgic amyotrophy is considered a rare peripheral nervous system disorder but
in practice seems grossly under recognized, which negatively affects care for these patients…

Background Alpha‐glucosidase inhibitors (AGIs) reduce blood glucose levels and may thus
prevent type 2 diabetes and cardiovascular disease in patients with impaired glucose …

One of the worst outcomes of acquired brain injury is the vegetative state, recently renamed ‘unresponsive
wakefulness syndrome’ ( VS / UWS ). A patient in VS / UWS shows reflexive …

Background Gout is one of the most frequently occurring rheumatic diseases, worldwide.
Given the well‐known drawbacks of the regular treatments for acute gout (non‐steroidal anti‐…

… Correspondence concerning this article should be addressed to Floris A. van de Laar,
Radboud University Nijmegen Medical Centre, Department of General Practice, 117 HAG, PO Box …